Intellectual Property & COVID-19

Navigating The IP Landscape During Uncertain Times

As coronavirus continues to alter our way of life, it also impacts the IP landscape. Staying up-to-date on the latest deadlines, court changes and overall business climate while managing your IP risks can feel overwhelming. The Wolf Greenfield team is here to help. This resource center includes:

Latest from Wolf Greenfield

Alerts, Articles & Blogs

Article COVID 2

COVID Prompts Compromise: Jury Trial Set to Proceed In-Person Partially

Courts are grappling with the question of when to resume jury trials and how to keep the litigants, attorneys, witnesses, jurors and court staff safe once they do. 

Read More

LitAlert

IP Litigation Timing Considerations in Light of COVID-19

Parties to pending or future IP litigation should consider the effects of COVID-19 related restrictions and measures when developing a strategy for moving cases forward. 

Read More

Blog Stairs Blue

COVID-19 Changes How Some Courts Consider Motions to Stay Pending IPR

In some instances, courts shifting resources to address COVID-19-related concerns is changing how courts evaluate motions to stay pending IPR.

Read More

LitAlert

IP Deadline Extensions Across The Globe Due to COVID-19

In this alert, we present a snapshot summary of actions taken by various IP offices with respect to extensions of deadlines and payment of fees due COVID-19.

Read More

Article COVID 2

WIPO Launches COVID-19 IP Policy Tracker

The World Intellectual Property Organization has launched the COVID-19 IP Policy Tracker, a tool that provides information on pandemic-related intellectual property office policy changes.

Read More

Article Columns

The Open COVID Pledge: What You Need to Know

Some organizations and institutions are pledging to make their intellectual property freely available to end the COVID-19 pandemic. This article discusses "The Open COVID Pledge."

Read More

Article COVID 3

One Size Does Not Fit All:

Courts Exercise Discretion in Addressing the Need for Remote Depositions in the Wake of COVID-19

Courts across the country are responding by modifying their standard procedures.

Read More

Article Chairs

Remote Depositions During COVID-19 and Beyond

While remote depositions are not a new aspect of litigators’ practice, the COVID-19 pandemic has forced many to adopt this previously underutilized aspect of discovery proceedings. 

Read More

Article COVID 3

The Impact of Foreign-Based Witnesses on COVID-Related Requests for Extensions

Recent orders in the Eastern District of Texas demonstrate the potential impact of foreign discovery during the pandemic.

Read More

Article Chairs

COVID-19: Impact on Patent Procedures

The impact COVID-19 has had on patent procedures. Topics covered include impact on United States practice, impact on European practice, other jurisdictions and  takeaways.

Read More

Article COVID 3

COVID-19 Prioritized Examination Pilot Program

The USPTO announced a new program designed to prioritize examination of patents geared towards the prevention or treatment of COVID-19.

Read More

Article Chairs

Hearings in the Time of COVID-19: Effective Representation While Remote

Effectively all hearings and oral arguments must be cancelled, rescheduled or conducted remotely. Here are insights gleaned from remote hearings.

Read More

Article COVID 1

Impact and 'Unintended Benefits' of the Federal Circuit's Suspension of In-Person Oral Arguments

This article on the Federal Circuit by Greg Corbett and Marie McKiernan was published in Law.com.             

Read More

Article Swirl Staircase

Pandemic Collaborations Pose Risk Of Future Patent Disputes

Dan Young was quoted by Law360 on the importance of taking a step back to make sure key IP issues are being addressed when forming COVID-19 collaborations.

Read More

Article COVID 1

Must the Show Go On? Some Judges Press Forward Scheduling Remote Patent Bench Trials

Two recent decisions indicate the judiciary’s willingness and desire to move patent cases along.

Read More

Blog Swirly Staircase

Appearing Before PTAB During COVID-19: What You Need to Know

Important changes practitioners should know regarding case management, CARES Act extensions and remote hearings at the PTAB.

Read More

Article COVID 1

Serving Notice While Six Feet Apart: Substituted Service in Light of COVID-19

This article explains what litigants on both sides of the “v.” need to know about service during the pandemic.   

Read More

Clients in the News

Our firm is lucky enough to work with clients that are making a difference in combatting COVID-19. Here are some of their interesting and impactful efforts.
Amgen-Logo-PNG-Transparent
Amgen-Logo-PNG-Transparent

Amgen and the Amgen Foundation have committed up to $12.5 million to support COVID-19 relief efforts.

Read More

 

analog-devices-01-logo-png-transparent
analog-devices-01-logo-png-transparent

The Analog Devices Foundation donated $500,000 to Massachusetts General Hospital’s Vaccine & Immunotherapy Center to advance COVID-19 vaccine development.

Read More

 

 

Becton_Dickinson_Logo_old-1
Becton_Dickinson_Logo_old-1

Beckton Dickinson is seeking emergency US approval to ramp up coronavirus tests. 

Read More

BioAegis_Basics_white_therapeutics_scaled
BioAegis_Basics_white_therapeutics_scaled

BioAegis is developing rhu-pGSN (recombinant human plasma gelsolin) based on a patent portfolio licensed from The Brigham and Women’s Hospital.

Read More

 

Boehringer_Ingelheim_Logo.svg
Boehringer_Ingelheim_Logo.svg

Boehringer Ingelheim donated $1 million in goods to the China Red Cross Foundation and is investigating antiviral compounds from past research against SARS-CoV2. 

Read More

Boston_Childrens_Hospital_logo
Boston_Childrens_Hospital_logo

Ofer Levy of Boston Children’s Hospital was interviewed by CNN about COVID-19.

Watch here.

 

download-3
download-3

Robots from Boston Dynamics are being used as a “mobile telemedicine platform” to minimize hospital staffs' exposure to COVID-19.

Read More

Their robots are also being used in Singapore to encourage social distancing.

Read More

Boxed.Logo.Green.RGB
Boxed.Logo.Green.RGB

Grocery delivery startup Boxed sees soaring demand amid pandemic. The company is prioritizing first responders’ orders. 

Learn More

BroadInstLogoforDigitalRGB
BroadInstLogoforDigitalRGB

The Broad Institute is contributing to Massachusetts’s COVID-19 diagnostic testing, developing new diagnostic technologies and data analysis tools, and generating new biological insights. 

Read More

ButterflyNetworks
ButterflyNetworks

Butterfly Network’s portable ultrasound can image lungs or hearts hurt from coronavirus and hopes to lessen the stress on the health care system. 

Learn More

comrad
comrad

Comrad has donated over $30,000 worth of compression socks to nurses and doctors at the front line and they are accepting donations to provide more.

Read More

 

 

DFCI
DFCI

Dana-Farber Cancer Institute began running low on critical PPE and researchers found a solution.

Read More

 

 

deka-logo-1
deka-logo-1

Dean Kamen of DEKA helped secure a shipment of protective equipment from China for New Hampshire.

Read More

 

 

1200px-FLIR_logo.svg
1200px-FLIR_logo.svg

FLIR Systems was quoted in an article about how thermal imaging cameras are the latest devices businesses hope will help reopen the economy.

Read More

 

Formlabs_logo
Formlabs_logo

Formlabs, University of South Florida Health, Northwell Health and Tampa General Hospital joined forces to create 3D printed nasal swabs to test for COVID-19 in patients in emergency shortage situations. 

Read More

In addition, the FDA granted Formlabs emergency clearance for 3D-printed ventilator component.

Read More

ginkgo
ginkgo

Ginkgo commits $25 million of free access to platform for partner COVID-19 projects. 

Read More

logo@2x
logo@2x

GreenLight Biosciences is expanding their vaccine efforts to establish a scalable current Good Manufacturing Practices (cGMP) manufacturing platform to allow for the production of almost any RNA-based COVID-19 vaccine at a scale and cost that enables global delivery. In addition, they are advancing a number of RNA-based vaccines and therapeutics against COVID-19.

Read More

 

jackson_laboratory
jackson_laboratory

The Jackson Laboratory (JAX) began providing coronavirus testing for CT residents.

Read More

JAX has also been working with researchers to reduce the long-term impact of the COVID-19 closings and to get them on track to return to normal once restrictions are lifted.

Read More

 

Rothberg Logo
Rothberg Logo

Biotech entrepreneur Jonathan Rothberg is developing a rapid COVID-19 home test kit that could return results to your smartphone in a half hour.

Read More

MIT Technology Review also featured Rothberg's efforts. 

Read More 

judy
judy

Judy, an in-case-of-emergency kit startup that is promising to be “ready for anything,” is working with experts to create curated disaster boxes based on where people live. 

Read More

jil
jil

Eli Lilly and Co. reached an agreement with the National Institutes of Health to study one of its drugs as a COVID-19 treatment. The drug is approved in more than 65 countries as a treatment for adults with moderately to severely active rheumatoid arthritis. 

Read More

They also opened labs and planned drive-thrus to help boost Indiana's COVID-19 testing capacity.

Read More

Kaleido-Blue-Transparent
Kaleido-Blue-Transparent

Kaleido Biosciences has initiated a controlled clinical study of Microbiome Metabolic Therapy KB109 in outpatients with mild-to-moderate COVID-19.

Read More

Since then, Kaleido Biosciences has initiated a controlled clinical study with Mass General Hospital of Microbiome Metabolic Therapy KB109 in outpatients with mild-to-moderate COVID-19.

Read More

Maverik-Brand-Logo-SVG-1
Maverik-Brand-Logo-SVG-1

Maverik Lacrosse shifts from helmets to making face shields for healthcare workers. 

Read More

 

mit-logo-png-2
mit-logo-png-2

A group at MIT figured out how to make an emergency ventilator for $100 using a common hospital item—instead of the usual $30,000. 

Read More

 

moderna height
moderna height

After recently starting human trials for a COVID-19 vaccine, Moderna was featured on 60 minutes. 

Read More

Since then, their potential coronavirus vaccine got $483 million boost from Feds.

Read More

Moderna announced positive interim Phase 1 data for its mRNA vaccine (mRNA-1273) against novel coronavirus.

Read More

nobull-coupons
nobull-coupons

NOBULL is donating thousands of CDC recommended face masks to medical professionals. They were able to access the masks from an FDA registered factory through their partners. They are accepting donations to procure face masks or other PPE for medical professionals. 

Read More

 

 

NEW
NEW

Nuance Communications announced the Nuance Dragon Ambient eXperience solution for telehealth providers.

Read More

 

 

opko-diagnostics-1-1
opko-diagnostics-1-1

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), will accept an Indefinite Delivery Indefinite Quantity (IDIQ) contract award to provide Commercial Surge Capacity Testing for COVID-19 Emergency Response to the Centers for Disease Control and Prevention (CDC).

Read more

 

 

persivia-logo-1
persivia-logo-1

Persivia releases AI-driven ruleset to detect COVID-19 novel coronavirus in patients. 

Read More

 

 

pluristem-1
pluristem-1

Position

Pluristem Therapeutics Inc. (PSTI) announced  it has treated its first patient suffering from COVID-19 under the FDA Single Patient Expanded Access Program.

Read More

1200px-Pfizer_logo.svg-1
1200px-Pfizer_logo.svg-1

Pfizer and BioNTech are co-developing a potential COVID-19 vaccine. 

Read More 

Pfizer and the Pfizer Foundation have also announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic in the US and around the world. 

Read More

g3fufk2akxzbwaz5jdgn
g3fufk2akxzbwaz5jdgn

PixMob is developing solutions that benefit frontline workers during the pandemic.

Read More

 

Quanterix-Logo
Quanterix-Logo

Researchers across the globe are deploying Quanterix Corporation’s Simoa® technology to profile innate immune response in COVID-19 patients, with the aim of identifying indicators associated with poor outcomes and opening new avenues for targeted therapies.

Read more

Logo_Takeda.svg-1
Logo_Takeda.svg-1

Takeda donated more than $6 million to fight coronavirus. 

Read More

They are also collaborating with other companies to accelerate development of potential COVID-19 Hyperimmune Therapy. 

Read More

translate bio smaller
translate bio smaller

Translate Bio and Sanofi Pasteur are collaborating to develop a novel mRNA vaccine candidate against COVID-19. 

Read More

 

 

Oyer, Tim small-1

Tim Oyer

President and Managing Partner

A Message from our President and Managing Partner

The sweeping impacts of COVID-19 are immeasurable and, at times, defeating. We have taken solace in the fact that people across the globe are coming together (while remaining socially distant) to help address and overcome this pandemic. As a firm, we feel incredibly fortunate to support clients across industries and geographies–some of whom were part of the earliest adopters in shifting gears and focusing on efforts to combat coronavirus.

During this unprecedented time, we want you to know that we are still here to help. We vow to provide you with the high level of service you deserve, and we will do everything we can to have a positive impact on you. We want our clients to be able to focus on their families and know their IP interests are safe with us.

Our sincere thoughts are with those impacted by the virus.

Our Team

If you have questions about how COVID-19 may impact your IP strategy, feel free to contact us.
Baker, Hunter small-1

Hunter Baker

Pharmaceutical Chair

Corbett, Greg small

Greg Corbett

Litigation Chair

Ferraro_Neil_small

Neil Ferraro

Mechanical Technologies Chair

Giunta, Rich small

Rich Giunta

Post-Grant Chair

Lockhart, Helen small

Helen Lockhart

Biotechnology Chair

Pritzker, Randy small retake

Randy Pritzker

Electrical Computer Technologies Chair

Walat, Rob small

Rob Walat

Chemical & Material Technologies Chair

Wolf, Doug small

Doug Wolf

Trademark & Copyright Chair

Additional Resources

Here are links to some resources we are regularly utilizing for intellectual property, business and health updates. This aggregated list is being frequently updated with more resources you may find helpful.

Wolf, Greenfield & Sacks, P.C.,© 2020 Wolf, Greenfield & Sacks, P.C. All Rights Reserved.

600 Atlantic Avenue, Boston, MA 02210, +1 617-646-8000 

605 Third Avenue, New York, NY 10158, +1 212-697-7890

WolfGreenfield.com